It is now well documented that free amino acids of blood are used for the synthesis of casein in the mammary tissue (Barry, 1961) . It is also known that phosphorus that is bound by ester linkage to the hydroxyl group ofthe serine of casein (Lipmann, 1933; Burnett & Kennedy, 1954 ) is supplied by inorganic phosphorus of blood (Aten & Hevesy, 1938; Barry, 1952; Kleiber & Luick, 1956 ). However, the mechanism by which phosphorus is incorporated into the protein molecule in the mammary gland has not yet been clearly delineated. Phosphorus atoms can be introduced either in the preformed polypeptide chains, or at the amino acid level, i.e. serine can be phosphorylated and phosphoserine thus formed can subsequently be incorporated into casein molecule. The former can occur while polypeptide chains are still attached to ribosomes or after their release from the ribosomal surface.
Puromycin, which inhibits the biosynthesis of protein by acting as an analogue of esterified RNA (Yarmolinsky & de la Haba, 1959) , is a very convenient and useful tool for studying the mode of incorporation of non-protein moieties into the conjugated proteins. For example, with the help of this antibiotic incorporation of iodine (Taurog & Howells, 1964; Soodak, Maloof & Sato, 1964; Tishler & Ingbar, 1965) and carbohydrates (Spiro & Spiro, 1966) Table 1 . Protein was estimated by the biuret method (Gornall, Bardawill & David, 1949) .
Treatment of 14C protein was as follows. At the end of incubation, the reaction was stopped by adding 2ml. of 10% (w/v) trichloroacetic acid. The tissue was homogenized and the homogenate spun at about 1000g for 10min. The residue was washed free of acid-soluble compounds, nucleic acids and lipids (Singh, Raghupathy & Chaikoff, 1965) . The dry protein powder thus obtained was dissolved in concentrated (88%) formic acid and samples were plated for 14C counting in a windowless gas-flow counter with about 40% efficiency.
Preparation of 32p samples for counting was as follows. The phosphoprotein phosphorus fraction was prepared for 32p counting essentially according to the method of Schmidt & Thannhauser (1945) as modified by Schmidt & Davidson (1956) . Phosphorus liberated during the alkaline hydrolysis of delipidated tissue was precipitated by adding magnesia mixture. Ammonium magnesium phosphate was recrystallized and dissolved in 0-1 N-HCI. Samples were used for estimation of inorganic phosphorus and 32p counting.
ResMlts and discu8sion. Data given in Table 1 show that, whereas 30min. incorporation of leucine carbon into protein by rat mammary-gland slices was inhibited by puromycin by about 80%, under similar experimental conditions that of [32P]P1 into phosphoprotein was practically unaffected. Puromycin is known to inhibit protein biosynthesis (Yarmolinsky & de la Haba, 1959 (Allen & Zamecnik, 1962; Nathans, 1964) . It is therefore to be expected that, if phosphorylation of serine precedes the incorporation of the amino acid into the casein molecule, puromycin will block the incorporation of [32P]P1 into the protein. Thus our present findings, showing no inhibition of 32p incorporation by puromycin, indicate that phosphorus atoms are introduced into the casein molecule after the formation of polypeptide chains. While this communication was in preparation a paper wherein authors have arrived at a similar conclusion with mouse mammary-gland explants has been published (Turkington & Topper, 1966) .
A study of the incorporation in vitro of [32P]Pi into phosphoprotein of mammary-gland tissue in the presence of puromycin as a function of time revealed that puromycin did not affect appreciably 32p incorporation during a 30min. incubation but did inhibit during longer intervals (1 and 2hr.) (Fig. 1 ). This suggests that there is perhaps a small pool of unphosphorylated or incompletely phosphorylated casein in the mammary-gland cells that can sustain the phosphorylation reaction even when the synthesis of new protein is blocked by puromycin, but when incubation period exceeds 30min. availability of non-phosphorylated precursor becomes a limiting factor and hence 32p incorporation into phosphoprotein is lowered in the absence of the formation of new protein. There has been little agreement on the site of inhibition ofAmytal and rotenone in the respiratory chain. Originally Chance (1956), on the basis of 'cross-over' experiments, proposed that Amytal inhibited NADE oxidation between substrate and flavoprotein. This conclusion was first widely accepted and was extended to rotenone by Oberg (1961) and Ernster & Lee (1964) , but Burgos & Redfearn (1965) and workers in our Laboratory (Minakami, Cremona, Ringler & Singer, 1963; Singer, 1966) reported that both of these agents inhibit between NADH dehydrogenase and ubiquinone in phosphorylating as well as non-phosphorylating preparations and pointed out that contrary observations could be traced to fallacies inherent in the 'cross-over' technique as applied to flavoproteins. Conclusive evidence that rotenone acts on the 02 side of the dehydrogenase has been presented by Horgan & Singer (1967) . On complete extraction ofNADHfdehydrogenase (also ofNADHubiquinone reductase) from particles inhibited by [6a-14C] rotenone, all the label remained attached to the residue containing the electron-transport system.
The availability of labelled rotenone prompted the extension of these studies to the determination of the reaction site of barbiturates and of the new antibiotic piericidin A (Eall, Wu, Crane & Folkers, 1966) in the NADH oxidase chain and to an investigation ofthe specificity, stoicheiometry and reversibility of rotenone binding. All methods were as in previous work (Horgan & Singer, 1967 Fig. l(a) shows that, although on titration of ETP* with rotenone the inhibition rises in a hyperbolic curve, as also found by Burgos & Redfearn (1965) , rotenone binding is quite linear, even though five times as much rotenone is. added as that required for maximal inhibition. When the titration was performed in the presence of 2% (w/v) bovine serum albumin, however, a biphasic binding curve was obtained, showing a rapid initial rise, corresponding to the specific binding site in the NADH dehydrogenase segment of the chain, and a slower secondary rise, representing binding at other points (Fig. lb, curve A) . The more the rotenonetreated particles were washed with 2% bovine serum albumin, the more evident became the biphasic nature of the curve. That the initial, rapidly rising, portion of the binding curve represents combination at the site involved in the inhibition of NADH oxidation and the linear part is due to unspecific binding is shown in curve B in Fig. 1(b) . Here the particles were first inhibited (98%) with unlabelled rotenone and then titrated with [14C]-rotenone. The initial phase of the curve is thereby almost completely abolished, but the slope of the linear portion remains essentially unaffected. Exactly the same effect may be observed if the particles are first inhibited with piericidin A, which * Abbreviation: ETP, electron-transport particles.
